Z-ROSU-FB - Manufacturers & Suppliers - Third Party Contract Manufacturing - PCD Pharma Franchise
FENOFIBRATE+ROSUVASTATIN is beneficial for the patients with Hypertriglyceridemia (high level of triglycerides), Hypercholesterolemia (high level of cholesterol), and Mixed Dyslipidaemia (elevated level of triglycerides – TG, low-density lipoprotein – LDL, and low level of high-density lipoprotein – HDL). Rosuvastatin first increases the LDL (bad cholesterol) on the liver cells for uptake and breakdown. Then, it stops the synthesis of very-low-density lipoprotein (VLDL) made by the liver to reduce the total number of bad cholesterols (LDL and VLDL). Fenofibrate works by increasing the enzyme (a natural substance) that breaks down fats or lipids present in the blood. Besides this, Fenofibrate also reduces the raised uric acid levels by increasing the excretion of uric acid through urination. It is also prescribed to diabetes patients with an increased level of lipid and cholesterol to minimize cardiovascular risks like heart attack, stroke, and heart-related chest pain (angina).
Drug-Drug Interaction: FENOFIBRATE+ROSUVASTATIN have shown interactions with immune system affecting medicine (cyclosporine), bile affecting pills (niacin, gemfibrozil, bile acid resin), anti-HIV drugs (lopinavir, ritonavir, atazanavir, ritonavir, tipranavir/ritonavir, fosamprenavir/ritonavir), anti-coagulant or blood thinners (coumadin, warfarin), and anti-arthritis pills (colchicine). So if you are taking these drugs tell your doctor before taking FENOFIBRATE+ROSUVASTATIN.
Drug-Food Interaction: High fat/lipid-containing food or drinks like processed foods, packed foods, pastries, cookies, cakes, alcoholic beverages (beer) should be avoided while taking FENOFIBRATE+ROSUVASTATIN.
Drug-Disease Interaction: FENOFIBRATE+ROSUVASTATIN should not be given in the condition of liver diseases like biliary cirrhosis (fatty liver disease), gall stones (cholelithiasis), kidney disease, muscle disease like myopathy, and rhabdomyolysis.